Related Experiment Videos
A patient with tremors and breathlessness
1Department of Respiratory Medicine, Warrington Hospital, Lovely Lane, Warrington, Cheshire WA5 1QG, UK. kamleshmohan@hotmail.com
Summary
Parkinson's disease patients on pergolide may develop serious lung issues like pleural effusions and fibrosis. Physicians should consider these drug-induced adverse effects in diagnosis.
Area of Science:
- Neurology
- Pulmonology
- Pharmacology
Background:
- Parkinson's disease is a neurodegenerative disorder.
- Pergolide, an ergot-derived dopamine agonist, is used for Parkinson's treatment.
- Adverse drug effects require careful monitoring.
Purpose of the Study:
- To report a case of bilateral pleural effusions and fibrosis.
- To highlight a potential adverse effect of pergolide therapy.
- To emphasize the importance of considering drug-induced conditions in differential diagnoses.
Main Methods:
- Case report.
- Clinical observation and patient history.
- Review of relevant literature.
Main Results:
- A patient with Parkinson's disease developed bilateral pleural effusions.
- The patient also exhibited pleural fibrosis.
- These conditions were associated with pergolide therapy.
Conclusions:
- Pergolide therapy may be associated with significant pulmonary complications.
- Physicians must maintain a high index of suspicion for drug-induced lung disease.
- Differential diagnoses should include medication side effects in patients with unexplained pleural abnormalities.